Sigachi Industries Ltd. a small-cap pharmaceutical company today announced a significant milestone for investors. In its latest exchange filing the company announced a significant achievement in its research and development (R&D) portfolio. The company announced the successful development of a new active pharmaceutical ingredient (API) combination—venzacaftor tezacaftor and dutivacaftor—for the treatment of cystic fibrosis (CF). According to the filing this achievement reflects the companys strategy to strengthen its presence in the complex and high-value specialty APIs space. The global market for cystic fibrosis drugs is estimated to be over $10 billion and the companys entry into this segment is good for its long-term goals. According to the filing based on the companys internal assessment Sigachi is exploring strategic partnerships with formulation innovators for this CF API portfolio. If these partnerships are successful the company expects to generate revenues of approximately ₹250 crore annually from the fourth quarter of fiscal year 2026-27. Lijo Chacko the companys deputy group CEO said this achievement demonstrates Sigachis capabilities in complex and differentiated APIs and will create sustainable value for stakeholders in the future. Importantly this API combination incorporates advanced chemistry and multi-step manufacturing limiting competition in this segment. Additionally patent protection on vanzacaftor extends until 2039 providing the company with long-term stable earnings. Sigachi Industries Share Price The companys stock was trading 2.02% or Rs 0.49 lower at Rs 23.74 on the BSE as of 11:42 am and on the NSE the stock was trading 1.65% or Rs 0.40 lower at Rs 23.78. Meanwhile benchmark equity indices Sensex and Nifty drifted lower in early trade on Wednesday as heightened geopolitical tensions weak global markets and persistent foreign fund outflows rattled investors sentiment. The 30-share BSE Sensex dropped 385.82 points to 81794.65 in opening trade. The 50-share NSE Nifty declined 91.5 points to 25141.
-
Best sleep-inducing plants that instantly calm your mind at night
-
Why Some Women Experience Long Labours While Others Don't
-
How to Use Telegram Usernames for Enhanced Privacy
-
Why Is Radha Worshipped Beside Krishna in Most Temples but Rarely Alone?
-
If Krishna Left Vrindavan, Why Did Radha Stay? The Mythological Reason
